p16(MTS-1/CDKN2/INK4a) in Cancer Progression

This publication has 183 references indexed in Scilit:

• Loss of p16/INK4A Protein Expression in Non-Hodgkin's Lymphomas Is a Frequent Finding Associated with Tumor Progression
  The American Journal of Pathology, 1998
• Alterations of CDKN2 (MTS1/p16INK4A) gene in paraffin-embedded tumor tissues of human stomach, lung, cervix and liver cancers
  Experimental & Molecular Medicine, 1998
• Codeletion ofCDKN2 andMTAP genes in a subset of non-Hodgkin's lymphoma may be associated with histologic transformation from low-grade to diffuse large-cell lymphoma
  Genes, Chromosomes and Cancer, 1998
• Molecular Analysis of the INK4 Family of Genes in Prostate Carcinomas
  Journal of Urology, 1997
• Mutations of the p16 gene product are rare in prostate cancer
  The Prostate, 1997
• Analysis of cyclin-dependent kinase inhibitor genes (CDKN2A, CDKN2B, andCDKN2C) in childhood rhabdomyosarcoma
  Genes, Chromosomes and Cancer, 1996
• Somatic Mutations of the MTS (Multiple Tumor Suppressor) 1/CDK41 (Cyclin-Dependent Kinase-4 Inhibitor) Gene in Human Primary Non-small Cell Lung Carcinomas
  Biochemical and Biophysical Research Communications, 1994
• Role for DNA methylation in genomic imprinting
  Nature, 1993
• A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
  Nature, 1993
• Insights into X chromosome inactivation from studies of species variation, DNA methylation and replication, and vice versa
  Genetics Research, 1990